Analystreport

Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) is now covered by analysts at B. Riley. They set a "neutral" rating and a $3.00 price target on the stock.

Arrowhead Pharmaceuticals, Inc.  (ARWR) 
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arrowheadpharma.com/investor-relations